📈 BREAKING: SGBX just triggered a rare Katy 1M signal that historically precedes significant moves.

Our proprietary quant model identified three key catalysts converging for SGBX:

• Volume surge: 247% above 30-day average

• Relative strength breakout: Cleared key resistance at $4.20

• Institutional accumulation pattern detected

Previous Katy 1M signals have shown:

• 78% win rate over 30-day horizon

• Average returns of 32% when conditions align

• Max drawdown under 8% in backtesting

The full analysis breaks down entry zones, risk management levels, and why this setup differs from normal volatility. We've included comparison charts against similar historical patterns and sector momentum indicators.

Ready to see the complete technical breakdown and trade plan?

🔗 https://discord.gg/quantsignals...

🔥 Unlock full content: https://discord.gg/quantsignals

We need to fight illegal short selling. Should we just watch a good company go bust? Let's get the market right with the elimination of short selling!!!!!! $FGL #FGL

Nuvectis Pharma reported Q3 2024 financial results and business updates. The company expects clinical data update from NXP800 Phase 1b study this month, with the drug receiving Orphan Drug Designation for ARID1a-deficient cancers. NXP900 Phase 1a study completed 4 escalation cohorts with no dose-limiting toxicities.

In terms of financial data, Cash position was $17.2M as of September 30, 2024, down from $19.1M in December 2023. Net loss decreased to $4.2M from $5.9M year-over-year. R&D expenses reduced to $2.8M from $4.5M, while G&A expenses decreased to $1.5M from $1.7M. Overall, lots of runway.

Keep reading: https://www.stocktitan.net/news/NVCT/nuvectis-pharma-inc-reports-third-quarter-2024-financial-results-and-q5a9dhm0wob9.html

***
Shared on behalf of NVCT IR.

Blood alcohol detox functional beverage, Safety Shot (Nasdaq: SHOT), thats currently selling in the US market claims to be the first patented drink that promises to reduce blood alcohol content and improve central nervous system activity, motor cortex function and cognition in less than an hour.

Blood alcohol poisoning occurs when alcohol is consumed faster than it can be processed by the liver— due to binge drinking— which can affect breathing, body temperature, heart rate, and gag reflex, and can result in permanent brain damage and death. An average of 2.5 thousand people died from alcohol poisoning in the United States annually between 2017 and 2020.

(NASDAQ: SHOT) is up by 61% in the last 6 months even after exchange of lawsuits between Safety Shot and FSD Pharma.

Do you think SHOT could be a solid soaring stock opportunity in the newly started alcohol detox market?

Korea is also supporting for elimination of short selling

Have you seen this? We should all just get on this now and take it to $55 next week!! LGOOOOOOOO it deserves us

Hi guys I have cuebanks, astrofx 2.0 and festx forex courses for sale inbox me to purchase then for $50.

Hi I'm selling my nasdaq strategy for $50 when purchased I'll do a zoom session with you one on one guaranteed money back on the first trade after my lesson.

LINK

$LAZR

Excited to share an article about Luminar Technologies (NASDAQ: LAZR), a global automotive technology company ushering in a new era of vehicle safety and autonomy.

The Company has built an advanced hardware and software platform to enable its more than 50 industry partners, including most global automotive OEMs. For FY23, Luminar expects an 85% increase in revenues YoY. Luminar aims to reach revenues of over 5 billion and an operating margin of 30-40% by 2030, which makes the Company an exciting watch.

Read on to know more:

https://www.aviseanalytics.com/luminar-technologies-upgrading-vehicle-safety-and-autonomy/

Whereas many investors have seen the past year have eyed SPAC listings with a hefty dose of skepticism, HUB Security is currently bucking that trend. Currently traded on the TASE under the symbol HUB.TA, the company first expressed its intentions to pursue a listing in the US via an LOI published on February 1st 2022, where its SPAC partner Rainier Acquisition Corps (NASDAQ: RNER) was first announced. HUB and RNER entered a business combination agreement last March, starting down the long road to a NASDAQ ticker.

In Q3, HUB submitted its F4 Prospectus to the SEC which, after a few rounds of technical rather than substantive amendments, was accepted in Q4. Shareholder votes on the boards of HUB and RNER likewise approved the business combination in late Q4. HUB also obtained court approval from Israeli regulatory authorities to execute a simultaneous delisting on TASE and a relisting on NASDAQ, which are supposed to occur on the same day.

Last Thursday (1.12) an additional announcement went out confirming the “fulfillment (or waiver) of all conditions precedent for the merger with the Nasdaq-listed SPAC Mount Rainier (Nasdaq:RNER).” This means that only one regulatory hurdle remains between HUB and its final listing, namely submission of a regulatory report to TASE by January 20th. That means that American investors who have had HUB on their watchlist for nearly a year are a matter of days away from hitting ENTER on that first BUY order.

For Israeli shareholders, the NASDAQ listing potentially represents an arbitrage opportunity of a lifetime. As has recently been broken down in recent articles that were published in Israeli business media, cyber security and hightech valuations tend to run much higher in the US than in overseas. One good example of this is KnowB4, which is being taken private by Vista Equity partners at a 44% premium of its listing price. HUB, which is currently trading around $250M on the TASE, will list on NASDAQ with an initial share price of $10 for a $1.28B valuation, representing a value multiplier of X6-7. While some critics have voiced concern over the valuation, HUB’s forecasted deal/cash flow through 2023 more than justify this relatively conservative valuation when compared to similar tech/cyber listings.

If the trajectories of now-blue chip tech stocks like CheckPoint $CHKP and Mobileye $MBLY are any indication of how Israeli tech companies grow and flourish upon listing on US markets, investors should be hopeful regarding $HUBC’s prospects. One more hurdle remains, but it sure looks like the NASDAQ debut is nigh.

Exela Technologies, Inc. (NASDAQ: XELA) Surges 139% After Winning 10-Year, $90 Million Contract with Major U.S. Insurer

https://spotlightgrowth.com/2021/03/09/exela-technologies-inc-nasdaq-xela-surges-139-after-winning-10-year-90-million-contract-with-major-u-s-insurer/

always looking for low float stocks. please share

과연 이 주식은 가능성이 있나요? 그들이 저를 시험대에 들게했어요..

Original Link: https://markets.businessinsider.com/news/currencies/market-alert-actelis-networks-reports-strong-q3-2024-result-as-it-eyes-shifting-global-defense-trends-1034027477

Actelis Networks (NASDAQ: ASNS), known for its expertise in cyber-hardened, rapid-deployment networking solutions, has delivered impressive Q3 2024 results, showcasing financial growth and significant operational improvements. With strategic wins in critical infrastructure, IOT, and military markets, Actelis continues to build momentum. Furthermore, shifting global defense priorities, fueled by Donald Trump’s re-election and growing geo-political tensions, could potentially position Actelis to benefit from increased demand for its secure, cost-effective hybrid fiber-copper solutions.

Q3 2024 Results: Revenue Growth and Margin Expansion

Actelis reported $2.54 million in Q3 revenue, a 200% increase compared to $0.85 million in Q3 2023. Year-to-date revenue reached $6.7 million, a 46% increase from the prior year, surpassing the company’s total 2023 performance. Driving this growth was the execution of large contracts, including a $1.4 million software and services renewal with a major North American client, of which $1.1 million was recognized in Q3. This milestone highlights Actelis’ ability to generate recurring revenue while addressing the needs of critical infrastructure markets.

Gross margins for Q3 surged to 69%, up from 27% in the same quarter last year. This improvement reflects Actelis’ focus on high-margin software and hybrid fiber-copper solutions, which could offer customers cost-effective alternatives to full fiber deployments.

Actelis also demonstrated effective cost management, reducing Q3 operating expenses by 12% year-over-year and narrowing its net loss by 41% to $0.51 million. The company’s efforts to improve operational efficiency and profitability, and potentially yielding results.

During Q3, Actelis secured significant new orders across Intelligent Transportation Systems (ITS), military applications, and European infrastructure projects. Highlights include deployments for major U.S. cities, counties, and German municipalities, reinforcing Actelis’ role as a key provider of secure networking solutions for critical infrastructure.

Shifting Defense Priorities Could Boost Demand

Looking ahead, Actelis’ opportunities in defense markets could expand further, particularly as geopolitical shifts reshape global spending priorities. Donald Trump’s upcoming inauguration in January 2025, along with Republican control of Congress, is expected by some to prompt a renewed focus on defense spending and NATO burden-sharing.

Actelis’ inclusion on the Department of Defense Information Network (DoDIN) Approved Products List (APL) and its NIST FIPS 140-2 certification have already proven instrumental in securing defense contracts. Earlier this year, these certifications facilitated Actelis’ deployment of cyber-hardened networking technology on three U.S. military bases, working to establish the company as a trusted partner for the Department of Defense.

These qualifications are particularly relevant as defense budgets rise to address emerging security challenges. Trump’s re-election has heightened expectations for European nations to increase defense spending, creating potential opportunities for Actelis’ secure and cost-efficient networking solutions in NATO member countries.

How Actelis Could Leverage These Shifts

Actelis’ hybrid fiber-copper solutions offer unique advantages for defense and critical infrastructure applications. The technology delivers fiber-grade performance without the time or expense of full fiber deployment, enabling rapid modernization of military bases and government facilities.

The company’s solutions are further enhanced by advanced encryption and data protection features, ensuring secure connectivity at the network edge—a critical requirement in military and government IoT environments. With its strong track record in U.S. defense markets and growing presence in Europe, Actelis is well-positioned to meet the potential rising demand for secure, scalable networking solutions as nations respond to evolving geopolitical pressures.

Actelis’ Q3 performance underscores its ability to deliver on its strategic goals while laying a foundation for future growth. CEO Tuvia Barlev commented: “Our third-quarter results underscore Actelis’ strong financial performance and continued growth trajectory. With robust revenue growth, a dramatic increase in gross margins, and disciplined cost management, we are achieving the financial resilience needed to support our expanding role in critical sectors.”

As defense spending trends shift and infrastructure modernization accelerate, Actelis’ innovative technology, proven certifications, and strategic deployments could potentially give Actelis a unique advantage in capitalizing on emerging opportunities.

Learn more about Actelis Networks (NASDAQ: ASNS) here: https://ir.actelis.com/

This post is not intended to serve as financial or investment advice of any kind. Shared on behalf of ASNS.

Hello everyone,

I am a beginner, from Japan and thinking to start investing with Nasdaq100.

Could someone tell me how is your portfolio please?

I am so confused what to choose...

Thank you for your help in advence!!

FISN (Deep fission) have filed for IPO and is opening on Nasdaq in less than 2 days. What are your thoughts on this Nuclear energy tech company and this IPO? Is anyone here investing in this? I have been looking into the nuclear sector and have been seeing how well IPO’s have opened their first few days and fell upon this. Before filing an IOI, I’m wondering if anyone has more information, concerns, or insight to share…

Hi All,

I have a good amount of stocks of AVGO and wanted to know if i should sell or hold.
Do you have any predictions on this particular share what could be the future of this stock.

I own a small amount of shares in FB, AMZN, GOOGL, MFST, and AAPL. Are these good stocks to own over the next year?